Company / Profit Margin
Centessa Pharmaceuticals plc Profit Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-1316.9%
FY2025
5-year range
-2204.7% / -1316.9%
FY2023-FY2025
Trend
-
vs FY2024
Sector context
#134 of 146
Health Care
What the data says
Among 146 Health Care companies, Centessa Pharmaceuticals plc is in the bottom 8% for profit margin.
Based on SEC 10-K filings.
-1316.9% in FY2025.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 146This company -1316.9% Sector average -796.3%
▼
-65.4% below sector average
Key checks
Key Insights
- Currently 520.6pp below the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1316.9% | - |
| FY2024 | - | - |
| FY2023 | -2204.7% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026